To print: Select File and then Print from your browser's menu

Title: Ibuprofen Suspension Effective Treatment For Paediatric Migraine

URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&list_uids=12390641&dopt=Abstract

Headache 2002; 42(8):780-786. "Children's Ibuprofen Suspension for the Acute Treatment of Pediatric Migraine."
11/07/2002 10:19:21 AM
By David Loshak

Paediatric ibuprofen suspension at an over-the-counter dose of 7.5 mg/kg relieves acute childhood migraines and is well tolerated. Specialists in paediatric neurology in Norfolk, Virginia, United States, drew attention, however, to a "striking difference" in response rates between the sexes. Boys responded at a statistically significant rate, the specialists said and because of a very high placebo responder rate, the girls did not. The specialists noted that migraine occurs in 4 percent of young children. There was little controlled clinical research in the treatment of childhood migraine and there were no approved drugs in the US for its treatment in children aged 12 years or younger. To assess the efficacy and tolerability of a single over-the-counter children's ibuprofen suspension 7.5 mg/kg versus placebo for the acute treatment of one attack of migraine, the specialists conducted a prospective, double-blind, placebo-controlled, parallel group, randomised study of children aged 6-12 years. There were two measures of efficacy. The first was headache severity based on a four point scale (severe, moderate, mild and no headache) at 30, 60, 90, 120, 180 and 240 minutes post-dose. The second was nausea, vomiting, photophobia and phonophobia at 120 minutes. The primary endpoint of the study was the cumulative percentage of responders (severe or moderate headache reduced to mild or none) by 120 minutes. Secondary endpoints were headache recurrence within 4 to 24 hours and any need for rescue medication within four hours. Of 138 children enrolled in the study, 84 were treated and completed diaries. Of these, 45 received ibuprofen and 39 received placebo. The two groups were demographically, diagnostically and clinically comparable. Nausea was eliminated in 60 percent of the children given ibuprofen compared with 39 percent of those given placebo - a statistically significant difference. Vomiting, photophobia and phonophobia fell marginally but not significantly at two hours.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R
Retrieve&db=PubMed&list_uids=12390641&dopt=Abstract

Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content.